Literature DB >> 1726151

Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case report.

J M Senard1, A Arias, M Berlan, M A Tran, A Rascol, J L Montastruc.   

Abstract

Sympathetic efferent pathways and alpha-adrenergic receptivity were investigated in one patient with spinal cord transection (D1 level) and orthostatic hypotension. The lack of increase in catecholamine plasma levels during orthostasis and the paradoxical pressor effect of clonidine (2 micrograms/kg orally) suggested complete interruption of efferent sympathetic pathways. The pressor response to exogenous noradrenaline was significantly higher in the patient than in 6 normal controls (0.09 vs 0.72 micrograms.kg-1), indicating supersensitivity of vascular alpha-adrenoceptors. The platelet alpha 2-adrenergic receptor number, measured with [3H]yohimbine, was 507 in the patient vs 178 fmol.mg-1 protein in controls. The increase in systolic blood pressure induced by 10 mg midodrine, a specific alpha 1-agonist, was significantly higher in the patient (delta = 56 mm Hg) than in controls (delta = 15 mm Hg). The results indicate that in the patient there was alpha-adrenergic supersensitivity both of alpha 1- and alpha 2-adrenoceptors. This led to successfully oral treatment of the orthostatic hypotension with clonidine 150 micrograms bd and midodrine 10 mg bd.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726151     DOI: 10.1007/bf00314991

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Enhanced pressor response to noradrenaline in patients with cervical spinal cord transection.

Authors:  C J Mathias; H L Frankel; N J Christensen; J M Spalding
Journal:  Brain       Date:  1976-12       Impact factor: 13.501

Review 2.  The central hypotensive action of clonidine and propranolol in animals and man.

Authors:  J L Reid; K K Tangri; L M Wing
Journal:  Prog Brain Res       Date:  1977       Impact factor: 2.453

Review 3.  [Adrenergic receptors of blood platelets].

Authors:  F Lanza; J P Cazenave
Journal:  Nouv Rev Fr Hematol       Date:  1987

4.  Steady state plasma [3H]-noradrenaline kinetics in quadriplegic chronic spinal cord injury patients.

Authors:  H Krum; D J Brown; P R Rowe; W J Louis; L G Howes
Journal:  J Auton Pharmacol       Date:  1990-08

5.  Clonidine raises blood pressure in severe idiopathic orthostatic hypotension.

Authors:  D Robertson; M R Goldberg; A S Hollister; D Wade; R M Robertson
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

6.  Sympathetic activity in man after spinal cord injury. Outflow to muscle below the lesion.

Authors:  L Stjernberg; H Blumberg; B G Wallin
Journal:  Brain       Date:  1986-08       Impact factor: 13.501

Review 7.  Autonomic dysreflexia in traumatic myelopathy.

Authors:  L S Kewalramani
Journal:  Am J Phys Med       Date:  1980-02

8.  Orthostatic hypotension-induced autonomic dysreflexia.

Authors:  R K Khurana
Journal:  Neurology       Date:  1987-07       Impact factor: 9.910

Review 9.  Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.

Authors:  D McTavish; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

10.  Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.

Authors:  J M Senard; P Valet; G Durrieu; M Berlan; M A Tran; J L Montastruc; A Rascol; P Montastruc
Journal:  Eur J Clin Invest       Date:  1990-12       Impact factor: 4.686

View more
  5 in total

1.  Lessons learned from the pilot study of an orthostatic hypotension intervention in the subacute phase following spinal cord injury.

Authors:  Bastien Moineau; Andrea Brown; Louise Brisbois; Vera Zivanovic; Masae Miyatani; Naaz Kapadia; Jane T C Hsieh; Milos R Popovic
Journal:  J Spinal Cord Med       Date:  2019-10       Impact factor: 1.985

Review 2.  A systematic review of the management of orthostatic hypotension after spinal cord injury.

Authors:  Andrei Krassioukov; Janice J Eng; Darren E Warburton; Robert Teasell
Journal:  Arch Phys Med Rehabil       Date:  2009-05       Impact factor: 3.966

3.  Systemic postganglionic adrenergic studies do not distinguish Parkinson's disease from multiple system atrophy.

Authors:  Axel Lipp; Paola Sandroni; Phillip A Low
Journal:  J Neurol Sci       Date:  2009-04-05       Impact factor: 3.181

4.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

5.  Management of Hypotension and Bradycardia Caused By Spinal Cord Injury. The Usefulness of Midodrine and Methylxanthines.

Authors:  Mojtaba Mojtahedzadeh; Hamidreza Taghvaye-Masoumi; Atabak Najafi; Mehrnoush Dianatkhah; Hamidreza Sharifnia; Maryam Shahrokhi
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.